3D Cell Culture Trends 2013

Publisher Name :
Date: 17-Jul-2013
No. of pages: 58

Executive Summary

  • This market report summarizes the results of HTStec’s 3rd industry-wide global web-based benchmarking survey on three dimensional (3D) cell culture technologies carried out in July 2013.
  • The study was initiated by HTStec as part of its ongoing tracking of this fast moving technology and emerging marketplace, and to update its previous report (published November 2011).
  • The main objectives of this global benchmarking study were to comprehensively document continuing interest in, experience gained and progress made in applying 3D cell culture technologies in academic research, drug discovery and tissue engineering/regenerative medicine settings, and to understand their future purchasing preferences.
  • The survey looked at the following aspects of 3D cell culture as practiced to date (2013) and in a few cases as predicted for the future (2015): current level of adoption (% all cell culture wells processed) of 3D cell culture technologies; areas where interest in 3D cell culture is primarily focused; type of 3D structure most interest in generating in culture; main intended applications of 3D cell culture; opinion on statements about 3D cell culture; most important advantages of 3D cell culture; approaches that have demonstrated most promise to date in facilitating 3D cell culture; vessel formats a 3D scaffold/matrix must have compatibility with; requirements for different types of 3D scaffold; different cell types used for 3D cell culture work; number of 3D wells per assay or project; total number of 3D wells per year; whether any high throughput (primary) screens using 3D technologies have been run to date; where 3D cell culture will make the biggest impact over the coming years; assay types successfully demonstrated using cells within a 3D matrix/structure; analytical technologies that have been applied to 3D cell culture today; how aspects of existing plate readers/imaging systems rate for use in the routine assay/detection/ interrogation of 3D cell culture derived structures; the most important tasks to automate in 3D cell culture; opinion on statements related to automating 3D cell culture; awareness of approaches/platforms used for the automation of 3D cell culture and tissue production/fabrication; interest in outsourcing 3D cell culture; interest in purchasing some assay-ready 3D constructs and outsourced 3D services; vendors that first comes to mind when you think of assay-ready 3D constructs and outsourced 3D services; interest in 3D organotypic microtissue models; level of success achieved with 3D cell culture; realistic adoption period for a new 3D scaffold; main barriers to the adoption of a new 3D matrix; whether 3D cell culture has reached its full market potential yet and what is still missing or where are the gaps/limitations in current 3D offerings; the relationship between spending on 3D consumable technologies versus other cell culture spending; budget for 3D cell culture consumables and its breakdown into components; 3D consumables most likely to be purchased in the future; suppliers of consumables and/or instruments that first come to mind and those most purchased from; and budget allocation to purchase new equipment to enable 3D culture.
  • The main questionnaire consisted of 30 multi-choice questions and 2 open-ended questions. In addition, there were 5 questions related solely to the administration of survey.
  • The survey collected 154 validated responses, of these 53% provided comprehensive input.
  • Survey responses were geographically split: 46% Europe; 31% North America; 12% Asia (excluding Japan); 6% Japan; and 5% Rest of World.
  • Respondents came from 83 University/Research Institute/Not-for-Profit Facilities; 21 Pharma; 15 Biotechs: 9 Other Organizations; 9 Hospitals/Clinics/Medical Schools; 5 Regen Med/Cell Therapy/Tissue Engineering Companies; 4 CROs; 3 Cosmetics Companies; 2 Government/Military/Defense Facilities; 2 Diagnostics Companies; and 1 Biomanufacturing/Bioprocessing Company.
  • Most survey respondents had a senior job role or position which was in descending order: 22 professors/ assistant professors; 19 research scientists; 18 principal investigators; 16 others; 16 senior scientists/researchers; 11 department heads; 11 lab managers; 10 directors; 9 graduate/PhD students; and 8 post-docs.
  • Respondents represented labs with the following main activity: 37 cancer research; 31 basic research; 27 drug discovery; 13 tissue/organ engineering; 10 preclinical research/ADME/toxicology; 9 stem cell biology; 8 regenerative medicine; 6 other; 6 cell therapy; 5 clinical research; and 1 developmental biology.
  • Survey results were expressed as an average of all survey respondents. In addition, were appropriate the data was reanalyzed after sub-division into the following 5 survey groups: 1) Academic Research; 2) Drug Discovery; 3) Tissue Engineering & Regenerative Medicine; 4) Europe; and 5) North America.
  • The median level of adoption was 30% of all cell culture wells processed involved a 3D technology.
  • The 3D structure respondents were most interested in generating in cell culture was spheroids.
  • The main application investigated using 3D cell culture was cancer therapy.
  • The level of agreement with some statements about 3D cell culture and 3D automation was recorded.
  • Better mirrors the environment experienced by normal cells in the body was rated the most important advantage of 3D cell culture.
  • Hydrogel scaffolds were ranked as the approach that had demonstrated most promise to date in facilitating 3D cell culture.
  • The 3D scaffold format most wanted was compatibility with the 96-well microplate.
  • The median requirements for 3D scaffolds with different types of properties were recorded.
  • Greatest use was made of transformed or recombinant cell lines in 3D cell culture work today (2013).
  • The median typical size of an assay or project in 3D cell culture was 50 assay wells today (2013).
  • The median number of assay wells setup per year with a 3D matrix was 200 today (2013).
  • The majority have not run any high throughput (primary) screens using 3D cell culture to date.
  • Cancer therapy was the application area where 3D cell culture is expected to make the greatest impact.
  • The assay type most used/investigated in a 3D cell culture matrix today (2013) was cell proliferation and cell viability.
  • The analytical technologies most applied in 3D culture today (2013) were fluorescence microscopy, brightfield/phase contrast microscopy and plate readers.
  • All aspects of existing plate readers/imaging systems were at best rated only moderately adequate, suggesting none performed as desired.
  • Respondent feedback on the most important tasks to automate with 3D cell culture and the challenges they pose for automation were documented.
  • Of some approaches to the automation of 3D cell culture respondents were most aware of: InSphero’s GravityPLUS™ platform; Corning® Costar® ultra-low attachment 96-well plates; Reinnervate’s Alvetex® 96-well plates; and 3D Biomatrix’s Perfecta3D™384-well plates.
  • Only a minority of respondents have outsourced 3D cell culture or related activity to date (2013).
  • Ready-made kits for specific cell-based assays developed within a 3D matrix were the 3D product or service respondents were most interested in accessing.
  • InSphero most comes to mind when thinking of assay-ready 3D constructs and outsourced services.
  • The 3D organotypic microtissue models respondents would like to see offered were documented with respect to organ or tissue, source, disease status required, and reasonable price for 96 tissues.
  • 39% of respondents rated their success achieved with 3D cell culture as major (significant improvement).
  • The median realistic adoption period for a new 3D scaffold was 6-9 months.
  • Budget constraints – can’t afford to change formats, was rated as the main barrier to the adoption of a new 3D matrix.
  • The majority think that 3D cell culture has not yet reached its full potential, feedback on what is still missing or where there are gaps/limitations in current 3D offerings were documented.
  • Around half of respondents total cell culture spending was still allocated to 2D cell culture.
  • The median budget allocated for spending on 3D cell culture consumables today (2013) was $10K-$25K. The biggest proportion of this budget was allocated to hydrogel 3D scaffolds.
  • A bottom-up model was developed around the respondent’s spending on 3D cell culture consumables to estimate the global market. In 2013 this market was estimated to be around $75M. Segmentation and CAGR estimates are given in the full report.
  • Hydrogel 3D scaffolds (purchased separate of culture vessel) and microplates designed to encourage spheroid generation were the 3D consumables respondents were most interested in purchasing.
  • BD Bioscience was the supplier of 3D cell culture consumables that first comes to the mind.
  • The most purchased from 3D cell culture consumables suppliers were BD Bioscience, Corning and InSphero. Combined these 3 suppliers have around 50% market share.
  • The median budget allocated for spending on 3D cell culture instruments today (2013) was <$5K.
  • The full report provides the data, details of the breakdown of the responses for each question, its segmentation and the estimates for the future (2015). It also highlights some interesting differences between the survey groups, particularly Academic Research versus Drug Discovery or Tissue Engineering & Regenerative Medicine.

3D Cell Culture Trends 2013

Table Of Contents

Executive Summary      2
Table of Contents     4
Survey Methodology    5
Main Group Activity & Response of Survey Participants    6
Respondent’s Geographic Origin    7
Respondent’s Company or Organisational Origin     8
Respondent’s Job Role       9
Respondent’s Main Area of Interest    10
Current Level of Adoption of 3D Cell Culture Methods    11
Type of 3D Structure Respondents Are Most Interested in Generating in Culture    12
Main Application of 3D Cell Culture    13
Opinion on Statements About 3D Cell Culture    14
Most Important Advantages of 3D Cell Culture    15
Approaches That Have Demonstrated Promise in 3D Cell Culture    16
3D Scaffold/Format Compatibility Requirement    17
3D Culture Requiring Different Types of Scaffolds  18
Summary of Survey Findings (1)    19
Current Use of Different Cell Types in 3D Cell Culture    20
Typical Size of an Assay or Project in 3D Cell Culture    21
Total Number of 3D Wells Setup Per Year With a 3D Matrix    22
Respondents Who Have Run Any HTS/Primary Screens Using 3D Cell Culture to Date    23
Biggest Impact of 3D Cell Culture    24
Assay Types Successfully Demonstrated in a 3D Cell Culture Matrix    25
Analytical Technologies Successfully Applied in 3D Cell Culture    26
How Aspects of Existing Plate Readers/Imaging Systems Rate for 3D Cell Culture Objects    27
Most Important Tasks to Automate With 3D Cell Culture & the Challenges They Pose for Automation    28
Opinion on Statements About 3D Cell Culture Automation       30
Use of Some Approaches for 3D Cell Culture Automation (1)    31
Use of Some Approaches for 3D Cell Culture Automation (2)    32
Interest in Outsourcing 3D Cell Culture    . 33
Interest in Purchasing Some 3D Derived Products or Services    34
Vendors That First Come to Mind for Assay-Ready 3D Constructs & Outsourced Services    35
Primary Interest in 3D Organotypic Microtissue Models    36
Secondary Interest in 3D Organotypic Microtissue Models    37
Summary of Survey Findings (2)    38
Current Level of Success Achieved With 3D Cell Culture     40
Realistic Adoption Period for a New 3D Scaffold     41
Main Barriers to the Adoption of a 3D Matrix      42
Has 3D Cell Culture Reached its Full Market Potential?    43
Spending on 3D Cell Culture Consumables Versus Other Cell Culture Spending    45
2013 Annual Budget for 3D Culture-Related Consumables    46
Breakdown of 2011 Budget for 3D Cell Culture Consumables    47
Market Estimate for 3D Cell Culture-Related Consumables    48
Breakdown of 3D Cell-Culture Related Consumables Market Estimate      49
3D Consumables Respondents are Most Interested in Purchasing    50
3D Cell Culture Suppliers That Comes to Mind (1)  51
3D Cell Culture Suppliers That Comes to Mind (2)  52
Most Purchased From Suppliers of 3D Cell Culture Consumables & Related Instruments (1)      53
Most Purchased From Suppliers of 3D Cell Culture Consumables & Related Instruments (2)      54
Estimated Supplier Share of 3D Consumables & Instruments Market    55
Capex Budget for 3D Cell Culture-Related Instrument Spending    56
Summary of Survey Findings (3)    57

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • 2014 Deep Research Report on Global and China Chitin Industry
    Published: 18-Nov-2014        Price: US $2600 Onwards        Pages: 183
    This is a professional and depth research report on Global Chitin industry. The report firstly introduced Chitin basic information included Chitin definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Chitin production and market share, Chitin industry policy and pl......
  • 2014 Deep Research Report on Global and China Bilirubin Industry
    Published: 18-Nov-2014        Price: US $2200 Onwards        Pages: 126
    This is a professional and depth research report on Global Bilirubin industry. The report firstly introduced Bilirubin basic information included Bilirubin definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Bilirubin production and market share, Bilirubin industr......
  • 2014 Deep Research Report on Global Human Albumin Industry
    Published: 18-Nov-2014        Price: US $3600 Onwards        Pages: 149
    This is a professional and depth research report on Global Human Albumin industry. The report firstly introduced Human Albumin basic information included Human Albumin definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Human Albumin production and market share, H......
  • 2014 Deep Research Report on Global and China Glass-ionomer Cement Industry
    Published: 17-Nov-2014        Price: US $2200 Onwards        Pages: 195
    This is a professional and depth research report on Global Glass-ionomer Cement industry. The report firstly introduced Glass-ionomer Cement basic information included Glass-ionomer Cement definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Glass-ionomer Cement pr......
  • Adocia – Product Pipeline Review – 2014
    Published: 14-Nov-2014        Price: US $1500 Onwards        Pages: 36
    Global Markets Direct's, ‘Adocia - Product Pipeline Review - 2014', provides an overview of the Adocia's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Adocia's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press rele......
  • Nuvilex, Inc. – Product Pipeline Review – 2014
    Published: 14-Nov-2014        Price: US $1500 Onwards        Pages: 21
    Global Markets Direct's, ‘Nuvilex, Inc. Product Pipeline Review 2014', provides an overview of the Nuvilex, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Nuvilex, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured ne......
  • Gamida Cell Ltd. – Product Pipeline Review – 2014
    Published: 14-Nov-2014        Price: US $1500 Onwards        Pages: 25
    Global Markets Direct's, ‘Gamida Cell Ltd. Product Pipeline Review 2014', provides an overview of the Gamida Cell Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Gamida Cell Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and fe......
  • Kuros Biosurgery AG – Product Pipeline Review – 2014
    Published: 14-Nov-2014        Price: US $1500 Onwards        Pages: 25
    Global Markets Direct's, ‘Kuros Biosurgery AG Product Pipeline Review 2014', provides an overview of the Kuros Biosurgery AG's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kuros Biosurgery AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest update......
  • Abera Bioscience AB – Product Pipeline Review – 2014
    Published: 14-Nov-2014        Price: US $1500 Onwards        Pages: 18
    Global Markets Direct's, ‘Abera Bioscience AB Product Pipeline Review 2014', provides an overview of the Abera Bioscience AB's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Abera Bioscience AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest update......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs